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Abstract
The interplay between the Apicomplexan parasite Toxoplasma gondii and its host has been
largely studied. However, molecular changes at the metabolic level in the host central ner-
vous system and pathogenesis-associated metabolites during brain infection are largely
unexplored. We used a global metabolomics strategy to identify differentially regulated
metabolites and affected metabolic pathways in BALB/c mice during infection with T. gondii
Pru strain at 7, 14 and 21 days post-infection (DPI). The non-targeted Liquid Chromatogra-
phy-Mass Spectrometry (LC-MS) metabolomics analysis detected approximately 2,755
retention time-exact mass pairs, of which more than 60 had significantly differential profiles
at different stages of infection. These include amino acids, organic acids, carbohydrates,
fatty acids, and vitamins. The biological significance of these metabolites is discussed. Prin-
cipal Component Analysis and Orthogonal Partial Least Square-Discriminant Analysis
showed the metabolites’ profile to change over time with the most significant changes
occurring at 14 DPI. Correlated metabolic pathway imbalances were observed in carbohy-
drate metabolism, lipid metabolism, energetic metabolism and fatty acid oxidation. Eight
metabolites correlated with the physical recovery from infection-caused illness were identi-
fied. These findings indicate that global metabolomics adopted in this study is a sensitive
approach for detecting metabolic alterations in T. gondii-infected mice and generated a
comparative metabolic profile of brain tissue distinguishing infected from non-infected host.
Introduction
The obligate intracellular Apicomplexan parasite Toxoplasma gondii is the etiological agent of
toxoplasmosis, a common parasitic diseases that affects virtually all vertebrate species including
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humans [1]. Humans or animals become infected congenitally from an infected mother to the
fetus, by ingestion of the parasite tissue cysts from undercooked or uncooked meat or by drink-
ing water contaminated with oocysts shed in feline feces [2]. Usually, the clinical spectrum of
the disease varies, depending on the host genetic background and genotype of the infecting
strain, from asymptomatic infection in immune-competent people to severe illness in pregnant
women and immunocompromised individuals [3]. Acute infection caused by the rapidly pro-
liferating tachyzoites is efficiently controlled by the immune system [4]. Tachyzoites then
transform into a slowly replicating stage (i.e. bradyzoites) enclosed in tissue cysts, and remain
dormant within the central nervous system (CNS) and muscles [5]. In immuno-compromised
individuals, latent infection can be reactivated and causes fatal consequences. For example,
toxoplasmic encephalitis (TE) in AIDS patients is caused by the reactivation of quiescent infec-
tion in CNS when CD4+ cells become<200 per μl [6].
Although infection in immune-competent people is generally benign, accumulating evi-
dence indicated that T. gondii infection could modify the host’s behavior and impair its learn-
ing capacity and memory [7]. Further evidence linked T. gondii infection to several mental
disorders, such as schizophrenia, mood disorders and suicidal behavior [8]. The pathogenic
mechanisms underlying T. gondii-induced behavioral and neuronal disorders remain largely
unknown. During T. gondii infection, host undergoes many pathophysiological changes
including metabolic, proteomic, histological changes, in order to maintain homeostasis and
adapt to the conditions that is required for its survival under challenge caused by the infecting
parasite. T. gondii can invade microglia, astrocytes, and neurons, with the majority of cysts are
found in neurons [9,10]. Microglia and astrocytes play important roles in intracerebral patho-
gen control by the production of antiparasitic and immunomodulatory effectors [11,12]. But,
the functional role of neurons is still largely unknown. In chronic infections, neuronal death
and lesions are caused by the production of nitric oxide (NO) and inflammatory cytokines
from immune cells [13]. Although much has been learned from such studies, they focus on
individual molecules and failed to reveal the global effects of infection on the host. There is a
need to elucidate the neuro-pathogenicity of this parasite and to identify infection-specific bio-
markers that differentiate between acute and chronic toxoplasmosis.
In recent years, the effects of T. gondii infections on the host’s brain have been studied with
comprehensive methods, such as transcriptomics and proteomics to identify differentially
expressed genes and proteins [14,15]. Metabolic profiling (i.e. metabolomics) is an emerging field
that involves identification and quantification of numerous low molecular weight compounds in
various biological samples. This approach provides a powerful means for the measurement of the
chemical phenotypes that are the net result of all activity on the transcriptome and proteome lev-
els; therefore, it provides an integrated global profile of the status of test organism [16–18]. Previ-
ous studies have focused only on targeted metabolites, such as dopamine and homovanillic acid
[19,20]. However, toxoplasmosis is very likely associated with a complex array of chemical reac-
tions and metabolites that stem from a diverse set of metabolic pathways associated with infection
and inflammation. Therefore, we hypothesized that due to changes in brain function and metabo-
lism caused by T. gondii infection, a characteristic pattern of metabolites would also be detectable.
The aim of this study was to determine whether metabolic profiling could be a reliable tool
to detect alteration in the metabolome of brain of T. gondii-infected mice. For this purpose,
BALB/c mice were experimentally infected with T. gondii Pru strain, and a LC-MS spectros-
copy-based metabolomics approach was used to identify a characteristic metabolic ‘biomarker
pattern’ in the brain of infected mice over the course of infection. The ability to discover signifi-
cantly altered individual metabolites or metabolic pathways linked to T. gondii infection has
been achieved. Physical recovery from acute toxoplasmosis has been correlated with biomark-
ers, which can be used as predictors of disease progression during T. gondii infection.
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Material and Method
Ethics statement
All animal procedures were approved by the Animal Ethics Committee of Lanzhou Veterinary
Research Institute, Chinese Academy of Agricultural Sciences (Permit No. LVRIAEC2014-
002). All experiments were performed in strict compliance with requirements of the Animal
Ethics Procedures and Guidelines of the People's Republic of China. We monitored infected
mice for adverse health issues and efforts were made to minimize suffering. All infected mice
were humanely euthanized by cervical dislocation under isoflurane inhalation anesthesia.
Mice
Female BALB/c mice were purchased from Lanzhou University, China. All mice had free access
to food and water and were kept in a temperature-controlled room (22 ±0.5°C) on reverse 12/
12 h light/dark cycle. Mice were acclimated for five to seven days before being used in the
experiment. Prior to initiation of the work mice were weighed (weight>20g) to establish a
baseline for detecting reduction in body weight caused by infection.
The parasite strain
Toxoplasma gondii type II Prugniuad (Pru) strain was maintained throughout the experiment
via oral inoculation of cysts in mice. Cysts used in this study were isolated from brain tissues of
infected BALB/c mice 40 days post-infection (DPI). Following anesthetizing animals, the
brains of the infected mice were removed and homogenized in a tissue homogenizer under
sterile conditions. Then, the number of cysts was counted and diluted to 100 cysts/ml in phos-
phate buffered saline solution (PBS).
Experimental infection and parasite detection in mice
Six- to eight-week-old BALB/c mice (n = 6 per group) were either left uninfected or inoculated
orally with freshly prepared 10 cysts of T. gondii Pru parasites using a small gavage needle.
Body weight was measured daily for 21 DPI, and all mice were checked daily for the develop-
ment of clinical signs characteristics of toxoplasmosis. Six mice from each of infected and con-
trol groups were sacrificed at 7, 14 and 21 DPI. Samples from blood, liver, spleen, lung, small
intestine and kidney were collected for the confirmation of the presence of T. gondii as previ-
ously described [21]. Briefly, genomic DNA was extracted from representative body tissue sam-
ples using TIANamp Genomic DNA kit (TianGen™, Beijing, China) according to the
manufacturer’s instructions. Specific PCR that targets 35-fold repeated B1 gene was applied to
detect T. gondii infection in mice tissues using the specific primers (50-AAC GGG CGA GTA
GCA CCT GAG GAG–30 and 50-TGG GTC TAC GTC GAT GGC ATG ACA AC–30). Positive con-
trol of DNA from parasites and negative controls (PBS) were included in each test. Also, pairs
of adjacent 5-mm square sections from brain samples collected at different time points post
infection were fixed in 10% neutral buffered formalin solution for 2 weeks, dehydrated in a
graded series of ethanol, embedded in paraffin wax, and then cut into 5μm-thick serial sections
on a microtome. They were then stained with hematoxylin and eosin [22]. Pathological
changes were observed under optical microscope.
LC-MS-based metabolomics
Unbiased metabolomic profiles of brain samples were obtained by using High Performance
Liquid Chromatography-Mass Spectroscopy (HPLC-MS). To minimize any potential changes
to the tissue metabolome, mice forebrains were rapidly removed and flash-frozen in liquid N2
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and stored at −80°C until processing. Nearly 100mg sample was homogenized in 500 μl of a
solvent of acetonitrile-water (7:3), treated with ultrasonic wave for 15 min. The mixture was
centrifuged at 12,000rpm for 15min, at 4°C. Supernatant (200 μl) was transferred to a new 1.5
ml polypropylene tube before liquid chromatography separation.
The LC-MS system was run in a binary gradient solvent mode consisting of 0.1% (v/v) for-
mic acid/water (solvent A) and 0.1% (v/v) formic/methanol (solvent B). The flow rate was 0.2
mL/min. A C18 column (Agilent Technologies, Santa, Clara, CA) (1.8 μm, 100×2.1 mm) was
used for all subsequent analysis. The linear gradient was as follows: 5% B at 0 min, 5% B at 2
min, 95% B at 17 min, and 95% B at 19 min.
Sample analysis was carried out in both positive electrospray ionization (ESI+) and negative
ion (ESI−) modes. The column temperature was 45°C and the injection volume was 5 μl.
LC-MS data was acquired using an Agilent 1290 Infinity LC System coupled to an Agilent 6530
Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) (LC-Q/TOF-MS). The mass scan range
was 100–1000 m/z. For positive ion mode, the capillary and cone voltage were set at 4 kV and
35 kV, respectively. Nitrogen was used as the dry gas. The desolvation gas was set to 600 L/h at
350°C; the cone gas was set to 50 L/h and the source temperature was set to 100°C. For negative
ion mode, the capillary and cone voltage were set at 3.5kV and 50 kV, respectively. The desolva-
tion gas was set to 700 L/h at 300°C; the cone gas was set to 50 L/h and the source temperature
was set to 100°C. The mass spectrometry was operated in V optics mode and the data acquisi-
tion rate was set to 0.03s, with interscan delay of 0.02s. To ensure accuracy and reproducibility
LockSpray was used in all analyses and Leucine-enkephalin was selected as the lockmass.
LC-MS data processing and statistics
Agilent MassHunter Workstation QTOF Acquistition software (B.03.01) was used for data
acquisition. LC-MS raw data files were converted into common format (.mzdata), which was
followed by data processing through the XCMS toolbox (http://metlin.scripps.edu/xcms/) [23].
Peak picking, peak grouping and retention time correction were all involved in data pre-treat-
ment, which were done through the XCMS software that was implemented with the freely
available R statistical language (v 2.13.1).
The retention time (RT)-m/z data pairs were used to indentify ion intensities of those
detected peaks. The consistent variables (ion intensity information) were obtained by filtering
peaks with 80% missing values. In order to remove the offsets and adjust the importance of
high and low abundance metabolites to an equal level, the data was preprocessed by both
mean-centering and variance-scaling prior to multivariate analysis. Then, the resulting three-
dimensional matrix that includes assigned peak indices (retention time-m/z pairs), sample
names and variables further went through the multivariate data analysis.
The resulting scaled datasets were imported into SIMCA-P+ 11.0 (Umetrics, Umea, Swe-
den) for processing using principal components analysis (PCA), PLS-discriminant analysis
(PLS-DA) and orthogonal partial least-squares-discriminant analysis (OPLS-DA), which were
carried out to visualize the maximal metabolic alterations between each group at all time
points. Metabolites found to be highly similar or discriminatory were compared to investigate
differential alteration at various time-points post infection. The differential metabolites were
selected when the statistically significant threshold of variable influence on projection (VIP)
values obtained from the OPLS-DA model was larger than 1.0. Meanwhile, the p values from a
two-tailed Student’s t-test on the normalized peak areas were less than 0.05 [24]. Log2 fold
change (FC) based on metabolite abundance was used to show how these selected differential
metabolites varied between groups. The positive value indicates the level of a specific metabo-
lite is increased. Meanwhile, the LC-MS abundance data set was imported into MeV software
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for heatmap generation. Diagnostic model was constructed by the marker metabolites that
were extracted from the combining VIP value, p value and fold change. The classification per-
formance (specificity and sensitivity) was assessed by the area under the curve (AUC) of the
receiver-operator characteristic (ROC) curves using SPSS software.
Metabolite Identification
Putative metabolites were first derived by searching the exact molecular mass data from redun-
dant m/z peaks against the online HMDB (http://www.hmdb.ca/), METLIN (http://metlin.
scripps.edu/) and KEGG (www.genome.jp/kegg/) databases. A specific metabolite was sieved
out when a match with a difference between observed and theoretical mass was less than
10 ppm. Then the metabolite molecular formula of matched metabolites was further identified
by the isotopic distribution measurement.
Results
Parasite infections in mice
Through the detection of T. gondii B1 gene, all infected mice were tested positive for T. gondii
infection (data not shown). Mice infected by T. gondii Pru strain showed normal body weight,
slight decline of feed consumption and slight signs of illness on day 7. However, physical condi-
tion of mice worsened over time and showed the typical clinical features of toxoplasmosis by
10 DPI, including anorexia, weight loss, edema and messy hair. More than half of the infected
mice began to return to healthy status on day 14 post infection. Mice in the control group
appeared normal and were tested negative for T. gondii infection during the whole experiment.
Using hematoxylin and eosin (HE) staining, brain samples (7, 14 and 21 DPI) were examined
for the severity and distribution of inflammation, tissue destruction, cell degeneration, and the
numbers of cysts. Uninfected control mice did not show any histological changes. No signifi-
cant pathologic changes were noted on 7 DPI. Mice in the infected group presented perivascu-
lar cuffing and glial nodule on 14 DPI, as shown in Fig 1A and 1B, respectively. More lesions
occurred as infection progressed. On 21 DPI, the number of purkinje cells increased in the
infected mice brains, which might be necessary for the survival of olivary neurons and cerebel-
lar granule cells [25]. Tissue cysts were intact and found multifocally throughout many sec-
tions, which appeared in the proximity of glial foci, as shown in Fig 1D.
Changes in brain metabolic profile with disease progression
Typical LC-MS base peak intensity (BPI) chromatogram of brain samples from different infec-
tion stages (7d, n = 6; 14d, n = 6; 21d, n = 5) and their corresponding control groups are shown
in Fig 2. Using the LC−MS analysis protocol and subsequent processes, we detected approxi-
mately 2755 retention time-exact mass pairs, 1065 in negative ionization mode and 1690 in
positive ionization mode. To analyze the profiling data from XCMS and identify samples that
are serious outliers, PCA was performed. As shown in S1 Fig, the ESI+ model explained 68.9%
of the variation in the metabolic profiling [R2X 68.9%] with a predictability of 45.3% [Q2
45.3%]. The ESI- model explained 67.2% of the variation in the metabolic profiling [R2X
67.2%] with a predictability of 37.9% [Q2 37.9%]. No outliers were observed in the data. Gener-
ally, the model is believed to be reliable when the R2X>0.4. The PCA results showed that the
infected and control mice brain samples were not clearly separated. All subsequent analyses
were carried out by Orthogonal Partial Least Square Discriminant Analysis (OPLS-DA). As
shown in Fig 3, the OPLS-DA score plot showed distinct clustering of the infected mice groups
and their corresponding control groups. Changes in metabolite profiles (positive or negative
Metabolomic Profiling in T. gondii Infected Mice Brains
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ion mode) over the time course of toxoplasmosis were similar, which indicated the metabolites
detected in both positive and negative ion modes might evolve over the time course of the
disease.
Global metabolic variations between infected and control mice
The differential metabolites associated with toxoplasmosis were identified according to VIP
threshold (VIP>1) and the P-value of student’s t-test after FDR correction. These identified
metabolites include amino acid, peptide, carbohydrate, lipid, nucleotide, cofactors and vita-
mins, and are involved in a wide range of biological pathways. The statistically significant
metabolites detected at different time points, their m/z values, log2 fold changes (FC) and
descriptions are shown in Table 1. Results showed that the number of significantly different
metabolites varied during the infection process and only a small set of metabolites exhibited
detectable periodic fluctuation nature. On day 7 (R2X = 0.277, R2Y = 0.889, Q2 = -0.837 ESI+;
R2X = 0.302, R2Y = 0.927,Q2 = -0.346 ESI-) (Fig 3A), the levels of phosphatidylcholine (PC)
(12:0), phosphatidylethanolamine (PE) (18:2), UDP-N-acetyl-D-galactosamine and aconitic
acid were found to be higher in the infection group relative to healthy control group, whereas
Fig 1. Histopathological lesions in mouse brain infected with Toxoplasma gondii Pru strain (10 cysts per mouse by oral route). (A)&(B) Infected
mice brain collected on day 14 PI. (A) Perivascular cuffing (triangle). (B) Glial nodule (diamond). (C)&(D) Infected mice brain collected on day 21 PI. (C)
Tissue cysts (arrow). (D) A glial focus (star) is found in the grey matter of the infected mice brain on day 21 PI. On both sides of it lie the tissue cysts (arrow).
Magnification (200×).
doi:10.1371/journal.pone.0139635.g001
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the levels of leukotriene D4 and inosine concentrations were found to be lower (Fig 4A, S2A
Fig). Among these metabolites, leukotriene D4 is an important inflammatory mediator, which
is formed through a cascade metabolism pathway from arachidonic acid [26].
On day 14 (R2X = 0.5, R2Y = 0.992, Q2 = 0.456 ESI+; R2X = 0.583, R2Y = 0.999,Q2 = 0.394
ESI- (Fig 3B), there were more altered metabolites. In the positive ion mode, levels of guano-
sine, guanine, hypoxanthine and inosine, important intermediates in purine metabolism, were
shown to be more abundant in the infected mice group compared to those in the control group
(Fig 4B). Other metabolites that are involved in crucial metabolic pathways, such as propionyl-
L-carnitine, acetylcarnitine and eicosapentaenoic acid, had similar changes. PC (18:0), PE
(21:0), PE (P–16:0), PC (15:0)/PE (18:0), PC (15:1)/PE (18:1) showed significantly increased
levels. Meanwhile, the levels of some other kind of phospholipids were found to be lower in the
infection group than the control group, including phosphatidylinositol (PI) (22:2), phospha-
tidic acid (PA) (18:3), PC (10:0) and PC (12:0). At the same time in the negative model, the lev-
els of PE (P–16:0/0:0), docosahexaenoic acid, PC (13:0)/PE (16:0), PC (15:0)/PE (18:0) and PE
(22:4) were found to be elevated. In contrast, the level of ribonic acid declined.
The number of differential metabolites in the infected mice brain decreased on day 21
(R2X = 0.921, R2Y = 1, Q2 = 0.73 ESI+; R2X = 0.55, R2Y = 0.988,Q2 = 0.572 ESI-) (Fig 3C).
Fig 2. Metabolites changing significantly with infection. Typical TIC chromatograms (TIC) of mice brain obtained in the positive ion mode (ESI+) (A) and
negative ion mode (ESI-) (B).
doi:10.1371/journal.pone.0139635.g002
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Fig 3. Orthogonal Partial Least Square Discriminant Analysis (OPLS-DA) score plot shows an excellent separation between infectedmice groups
and control groups. (A) The 7 day infected group (7I) and the 7 day control group (7C); (B) The 14 day infected group (14I) and the 14 day control group
(14C); (C) The 21 day infected group (21I) and the 21 day control group (21C). In OPLS-DA score plot, each data point represents one mouse brain sample,
and the distance between points in the plot indicates the similarity between samples. a. ESI+, b. ESI-. X axis is PC1, y axis is PC2.
doi:10.1371/journal.pone.0139635.g003
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Table 1. List of differentially-expressedmetabolites identified at different stages of infection (infected “I” vs control “C”).
VIP m/z Rt
(min)
metabolites F.C.
*
p-value Metabolic pathways
7I/7C(+) 2.897 454.2596 5.79 PC(12:0) 0.58 2.56E-
02
Not known
3.370 497.2694 4.82 Leukotriene D4 -1.03 5.74E-
03
Arachidonic acid metabolism
7I/7C(-) 2.275 476.2775 11.57 PE(18:2) 0.84 4.16E-
02
Not known
2.841 606.0742 1.68 UDP-N-acetyl-D-galactosamine 0.73 5.10E-
03
Amino sugar and nucleotide sugar metabolism
2.756 267.0733 0.85 Aconitic acid 0.33 7.65E-
03
TCA cycle
2.389 173.0088 1.09 Inosine -0.25 2.98E-
02
Purine metabolism
14I/14C
(+)
1.363 524.3713 13.25 PC(18:0)/ PE(21:0) 2.11 2.72E-
02
Not known
1.809 284.0995 1.24 Guanosine 2.09 6.32E-
04
Purine metabolism
1.415 152.0565 1.24 Guanine 2.03 2.02E-
02
Purine metabolism
1.356 218.1388 0.95 Propionyl-L-carnitine 1.86 2.82E-
02
Not known
1.807 137.0457 1.26 Hypoxanthine 1.8 6.46E-
04
Purine metabolism
1.867 269.0888 1.26 Inosine 1.79 2.64E-
04
Purine metabolism
1.537 438.2982 12.43 PE (P–16:0) 1.54 9.16E-
03
Not known
1.493 482.3246 13.09 PC(15:0)/ PE(18:0) 1.52 1.25E-
02
Not known
1.257 204.1231 0.87 Acetylcarnitine 1.48 4.64E-
02
Not known
1.249 303.2323 12.57 Eicosapentaenoic Acid 1.2 4.82E-
02
Biosynthesis of unsaturated fatty acids
1.555 480.3089 12.39 PC(15:1)/ PE(18:1) 0.98 8.03E-
03
Not known
1.246 520.3401 11.76 PC(18:2) 0.79 4.88E-
02
Not known
1.393 518.3222 12.22 PC(18:3) 0.42 2.31E-
02
Not known
1.315 163.9779 0.74 Selenocysteine -0.3 3.49E-
02
Selenocompound metabolism
1.385 302.3059 10.64 Sphinganine -0.33 2.41E-
02
Sphingolipid metabolism
1.270 175.1189 0.72 Arginine -0.37 4.37E-
02
Arginine and proline metabolism
1.814 509.4306 5.87 DG(28:2) -0.6 5.90E-
04
Not known
1.396 214.0116 0.91 4-Phospho-L-aspartate -0.62 2.27E-
02
Glycine, serine and threonine metabolism
1.428 454.2596 5.79 PC(12:0) -0.73 1.87E-
02
Not known
1.469 426.2259 4.73 PC(10:0) -0.74 1.45E-
02
Not known
(Continued)
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Table 1. (Continued)
VIP m/z Rt
(min)
metabolites F.C.
*
p-value Metabolic pathways
1.299 433.233 4.70 PA(18:3) -0.75 3.79E-
02
Not known
1.262 653.3687 7.47 PI(22:2) -0.81 4.53E-
02
Not known
1.600 468.992 5.57 dUTP -1.14 5.63E-
03
Pyrimidine metabolism
1.633 422.2641 7.59 N-acetylsphingosine
1-phosphate
-1.2 4.25E-
03
Not known
1.588 129.0659 1.37 L-γ-Cyano-γ-aminobutyric acid -1.28 6.21E-
03
Not known
1.523 104.0714 1.37 γ-Aminobutyric acid -1.38 1.01E-
02
Not known
1.397 244.0932 1.46 Cytidine -1.47 2.26E-
02
Pyrimidine metabolism
1.677 142.0264 1.33 O-Phosphorylethanolamine -1.47 2.86E-
03
Glycerophospholipid and sphingolipid metabolism
1.625 597.5586 7.76 DG(34:0) -1.78 4.57E-
03
Not known
1.707 184.0735 1.37 Phosphocholine -1.8 2.12E-
03
Glycerophospholipid metabolism
1.790 134.0449 1.38 L-Aspartic Acid -1.91 8.10E-
04
Alanine, aspartate and glutamate metabolism
1.852 126.022 1.39 Taurine -2 3.35E-
04
Primary bile acid biosynthesis; Taurine and hypotaurine
metabolism
14I/14C
(-)
1.458 436.2827 12.10 PE(P–16:0/0:0) 1.23 2.85E-
02
Not known
1.711 327.2325 14.66 Docosahexaenoic acid 1.06 6.13E-
03
Biosynthesis of unsaturated fatty acids
1.522 452.2777 11.85 PC(13:0)/ PE(16:0) 1.01 2.04E-
02
Not known
1.387 480.3088 12.71 PC(15:0)/ PE(18:0) 1 4.00E-
02
Not known
1.453 528.3086 12.09 PE(22:4) 0.66 2.91E-
02
Not known
1.543 303.2326 14.83 Arachidonic Acid 0.6 1.82E-
02
Arachidonic acid metabolism
1.365 500.2778 11.59 PE(20:4) 0.6 4.40E-
02
Not known
1.622 175.0251 1.94 Ascorbic acid 0.47 1.13E-
02
Ascorbate and aldarate metabolism
1.467 203.0822 3.17 Tryptophan 0.35 2.73E-
02
Tryptophan metabolism
1.421 131.0381 0.60 Glutaric acid -0.33 3.41E-
02
Fatty acid metabolism
1.697 165.0405 14.40 Ribonic acid -1.45 6.81E-
03
Not konwn
21I/21C
(+)
2.282 308.0909 0.92 Glutathione 1.84 8.35E-
03
Cysteine and methionine metabolism
2.019 258.1104 0.87 Glycerophosphocholine 1.35 2.83E-
02
Not known
21I/21C
(-)
1.631 214.0467 0.64 Glycerylphosphorylethanolamine 0.74 4.57E-
02
Not known
(Continued)
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Under the ESI+ model, glutathione, which functions as an important antioxidant preventing
damage to cellular components, was shown to be more abundant in the infection group than in
the control group (Fig 4C). Another key metabolite, glycerophosphocholine, which plays an
important role in improving the brain function, has the same profile. Under the ESI- model,
levels of glycerylphosphorylethanolamine, uridine monophosphate and uridine were higher in
infected mice (S2C Fig). The rare amino acid pyroglutamic acid (a metabolite in the glutathi-
one cycle) was shown to be less abundant in the infection group. Metabolites that have the sim-
ilar profiles included citric acid and pantothenic acid. Phospholipids that are a major
component of all cell membranes were found to be down-regulated at this period, including PE
(18:2), PE (P–16:0/0:0), PC (15:0)/ PE (18:0), PC (13:0)/ PE (16:0), PC (13:0), and PC (15:1)
/PE (18:1).
Table 1. (Continued)
VIP m/z Rt
(min)
metabolites F.C.
*
p-value Metabolic pathways
2.152 323.0298 0.70 Uridine monophosphate 0.73 2.01E-
03
Not known
1.751 243.0616 0.86 Uridine 0.71 2.76E-
02
Pyrimidine metabolism
1.964 149.0452 0.68 Ribose 0.4 8.80E-
03
Carbon metabolism
1.650 346.0557 0.72 dGMP 0.31 4.24E-
02
Purine metabolism
1.912 146.0459 0.67 Glutamate 0.24 1.21E-
02
Alanine, aspartate and glutamate metabolism
2.043 179.0552 0.64 α-D-Glucose 0.22 5.09E-
03
Not known
1.675 102.0559 0.67 γ-Aminobutryic acid 0.2 3.83E-
02
Not known
1.715 154.0618 0.61 Histidine -0.21 3.23E-
02
Histidine metabolism
1.746 191.0198 0.81 Citric acid -0.4 2.83E-
02
TCA cycle
1.663 500.2778 11.59 PE(20:4) -0.44 4.02E-
02
Not known
2.017 128.0355 0.85 Pyroglutamic acid -0.54 6.16E-
03
Glutathione metabolism
1.733 478.2933 12.08 PC(15:1)/ PE(18:1) -0.62 3.00E-
02
Not known
1.654 452.2777 11.85 PC(13:0)/ PE(16:0) -0.73 4.17E-
02
Not known
1.785 480.3088 12.71 PC(15:0)/ PE(18:0) -0.78 2.36E-
02
Not known
1.774 218.103 2.18 Pantothenic Acid -0.81 2.49E-
02
beta-Alanine metabolism; Pantothenate and CoA
biosynthesis
1.641 436.2827 12.10 PE(P–16:0/0:0) -0.89 4.38E-
02
Not known
1.904 476.2775 11.57 PE(18:2) -1.19 1.27E-
02
Not known
* indicates log2 fold change
+ indicates ESI+ mode
- indicates ESI- mode
doi:10.1371/journal.pone.0139635.t001
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Differential expression of host brain metabolomes among T. gondii
infected mice groups
To understand the metabolomic changes in the mice brain during different stages of T. gondii
infection, a two-component OPLS-DA model was constructed to achieve a distinct separation
between different infection groups (Fig 5). As shown in Table 2, there were many significant
alterations in the brain levels of several metabolites, especially between 14 DPI group and 7
DPI group (R2X = 0.77, R2Y = 1, Q2 = 0.892 ESI+; R2X = 0.36, R2Y = 0.962,Q2 = 0.594 ESI-)
(Fig 5A). In the positive ion mode, the levels of pantothenic Acid, propionyl-L-carnitine,
3-ketosphingosine, hypoxanthine and inosine were significantly higher in the brain on 14 DPI
(Fig 6A). Up-regulated metabolites in negative ion mode included N-Acetylleucine, FMN and
ascorbic acid. Meanwhile in the same ion mode, metabolites that were significantly down-regu-
lated included taurine, L-Aspartic acid, ascorbic acid, phosphocholine, γ-aminobutryic acid, o-
phosphorylethanolamine, dUTP, N-acetylsphingosine 1-phosphate, choline and acetyl-CoA.
Most significantly altered phospholipids were up-regulated no matter in positive ion mode or
negative ion mode (Fig 6A, S3A Fig). Only the levels of PC (12:0) and PI (22:2) (log2 fold
change:-1.12, -0.74, respectively) were decreased. These results showed that phospholipids
anabolism was active during the transitional phase from physical illness to recovery.
Brain samples from 21 DPI group and 14 DPI group showed a very high segregation
(R2X = 0.412, R2Y = 0.958, Q2 = 0.343 ESI+; R2X = 0.857, R2Y = 1, Q2 = 0.587 ESI-), as shown
in Fig 5B. The same distinct metabolic profiles were not seen between 21DPI group and 7DPI
group (R2X = 0.525, R2Y = 0.974, Q2 = 0.373 ESI+; R2X = 0.568, R2Y = 0.963,Q2 = 0.332 ESI-)
Fig 4. Comparison of the mice brain metabolomes during the course of infection. Heat maps representing the significantly changed metabolites
between infected groups and the corresponding control groups in ESI+ mode (A, B and C). Normalized metabolite abundance (log2 transformed and row
adjustment) are visualized as a color spectrum and the scale from least abundant to highest ranges is from -2.0 to 2.0. Green indicates low expression,
whereas red indicates high expression of the detected metabolites. (A) 7D infected group (7I) vs 7D control (7C); (B) 14D infected group (14I) vs 14D control
(14C); (C) 21D infected group(21I) vs 21D control (21C).
doi:10.1371/journal.pone.0139635.g004
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Fig 5. OPLS-DA score plot showed a clear separation between the infected brain samples at different time points. (A) The 7 day group and the 14
day group; (B) The 21 day group and the 14 day group; (C) The 21 day group and the 7 day group. In OPLS-DA score plot, each data point represents one
mouse brain sample, and the distance between points in the plot indicates the similarity between samples. a. ESI+, b. ESI-. X axis is PC1, y axis is PC2.
doi:10.1371/journal.pone.0139635.g005
Metabolomic Profiling in T. gondii Infected Mice Brains
PLOS ONE | DOI:10.1371/journal.pone.0139635 October 2, 2015 13 / 22
Table 2. List of identified metabolites that varied between different infection stages.
VIP m/z Rt
(min)
metabolites F.C.
*
p-value Metabolic pathways
14d/7d(+) 1.344 524.3713 13.25 PC(18:0)/ PE(21:0) 2.36 3.00E-02 Not known
1.857 438.2982 12.43 PE (P–16:0) 2.26 0.00E
+00
Not known
1.719 482.3246 13.09 PC(15:0)/ PE(18:0) 1.86 2.00E-03 Not known
1.639 220.1185 2.32 Pantothenic Acid 1.78 4.00E-03 beta-Alanine metabolism; Pantothenate and CoA
biosynthesis
1.294 218.1388 0.95 Propionyl-L-carnitine 1.67 3.90E-02 Not known
1.555 298.2745 10.47 3-ketosphingosine 1.65 8.00E-03 Not known
1.536 137.0457 1.26 Hypoxanthine 1.38 9.00E-03 Purine metabolism
1.509 269.0888 1.26 Inosine 1.34 1.10E-02 Purine metabolism
1.815 480.3089 12.39 PC(15:1)/ PE(18:1) 1.12 1.00E-03 Not known
1.791 161.128 0.62 Ne-Methyl-L-lysine 0.27 1.00E-03 Not known
1.420 302.3059 10.64 Sphinganine -0.34 2.00E-02 Sphingolipid metabolism
1.497 810.1145 8.70 Acetyl-CoA -0.5 1.20E-02 Taurine and hypotaurine metabolism; Glutathione
metabolism
1.415 509.4306 5.87 DG(28:2) -0.53 2.00E-02 Not known
1.507 104.1071 0.74 Choline -0.69 1.10E-02 Glycine, serine and threonine metabolism
1.440 653.3687 7.47 PI(22:2) -0.74 1.80E-02 Not known
1.544 422.2641 7.59 N-acetylsphingosine
1-phosphate
-1.04 9.00E-03 Not known
1.752 454.2596 5.79 PC(12:0) -1.12 1.00E-03 Not known
1.533 468.992 5.57 dUTP -1.28 1.00E-02 Pyrimidine metabolism
1.335 142.0264 1.33 O-Phosphorylethanolamine -1.38 3.20E-02 Glycerophospholipid metabolism
1.534 104.0714 1.37 γ-Aminobutryic acid -1.52 9.00E-03 Not known
1.245 184.0735 1.37 Phosphocholine -1.53 4.90E-02 Glycerophospholipid metabolism
1.406 134.0449 1.38 L-Aspartic Acid -1.73 2.20E-02 Alanine, aspartate and glutamate metabolism
1.502 126.022 1.39 Taurine -1.81 1.20E-02 Primary bile acid biosynthesis
1.777 597.5586 7.76 DG(34:0) -1.83 1.00E-03 Not known
14d/7d(-) 1.849 436.2827 12.10 PE(P–16:0/0:0) 3.71 6.74E-04 Not known
1.682 172.0975 5.79 N-Acetylleucine 2.8 3.96E-03 Not known
1.965 452.2777 11.85 PC(13:0)/ PE(16:0) 2.74 1.06E-04 Not known
1.838 480.3088 12.71 PC(15:0)/ PE(18:0) 2.4 7.78E-04 Not known
1.947 478.2933 12.08 PC(15:1)/ PE(18:1) 1.85 1.49E-04 Not known
1.663 455.0968 4.85 FMN 1.69 4.67E-03 Riboﬂavin metabolism
1.665 175.0251 1.94 Ascorbic acid 1.25 4.61E-03 Ascorbate and aldarate metabolism
21d/14d
(+)
1.943 258.1104 0.87 Glycerophosphocholine 1.15 2.12E-02 Not known
1.715 220.1185 2.32 Pantothenic Acid -1.05 4.23E-02 beta-Alanine metabolism; Pantothenate and CoA
biosynthesis
21d/14d
(-)
1.727 214.0467 0.64 Glycerylphosphorylethanolamine 0.53 4.47E-02 Not known
1.898 131.0380 0.60 Glutaric acid 0.38 2.28E-02 Fatty acid metabolism
1.881 128.0355 0.85 Pyroglutamic acid -0.43 2.46E-02 Glutathione metabolism
21d/7d(+) 1.159 227.1116 0.63 Carnosine -0.46 3.20E-02 Histidine metabolism
1.507 104.1071 0.74 Choline -0.54 3.40E-02 Glycine, serine and threonine metabolism
1.752 454.2596 5.79 PC(12:0) -0.82 3.40E-02 Not known
21d/7d(-) 1.989 145.0143 0.83 Oxoglutaric acid 1.87 2.10E-02 TCA cycle
1.843 214.0467 0.64 Glycerylphosphorylethanolamine 0.4 3.80E-02 Not known
(Continued)
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(Fig 5C), in which Q2 were less than 0.4 in both ion modes. The number of significantly
changed metabolites was very small between 21 DPI group and 14 DPI group. Glyceropho-
sphocholine was the highest abundance metabolite (log2 fold change = 1.15) and pantothenic
acid was the lowest (log2 fold change = -1.06) (Fig 6C). Comparisons between 21 DPI group
and 7 DPI group showed that oxoglutaric acid, also called α-ketoglutarate (an intermediate in
the Krebs cycle), was shown to be more abundant (log2 fold change = 1.87) (S3B Fig). The level
of carnosine, choline and citric acid were slightly decreased. Glycerylphosphorylethanolamine,
known to improve in vivo the learning and memory processes, was up-regulated.
Identification of potential biomarkers
Infected mice began to restore their health on day 14, showing an increased appetite and
enhanced mental state. We then investigated metabolites that have the potential to be used as
biomarkers for the prediction of physical recovery from acute T. gondii infection. To select
Table 2. (Continued)
VIP m/z Rt
(min)
metabolites F.C.
*
p-value Metabolic pathways
2.062 175.0251 1.94 Ascorbic acid 0.35 1.50E-02 Ascorbate and aldarate metabolism
2.184 455.0968 4.85 FMN 0.29 8.00E-03 Riboﬂavin metabolism
2.261 191.0198 0.81 Citric acid -0.42 5.00E-03 TCA cycle
1.805 739.4354 7.94 PA(40:10) -1.12 4.30E-02 Not known
* indicates log2 fold change
+ indicates ESI+ mode
- indicates ESI- mode
doi:10.1371/journal.pone.0139635.t002
Fig 6. Heat map showing the significantly dysregulated metabolites identified between different infected groups in ESI+ mode.Heat maps show a
clear separation of the metabolomic profile between different infected groups. Normalized metabolite abundance (log2 transformed and row adjustment) are
visualized as a color spectrum and the scale from least abundant to highest ranges is from -2.0 to 2.0. Green color indicates low expression, and red color
indicates high expression of the detected metabolites. (A) 7D infected group (7I) vs 14D infected group(14I); (B) 7D infected (7I) group vs 21D infected group
(21I); (C) 14D infected group (14I) vs 21D infected group (21I).
doi:10.1371/journal.pone.0139635.g006
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potential marker metabolites, differential metabolites identified on the 14 day were subjected
to ROC analysis. The differentiation performance (specificity and sensitivity) was assessed by
the area under the curve (AUC>0.85) and eight significantly differential metabolites were
selected as potential biomarkers, as shown in Table 3. Some marker metabolites are involved in
purine metabolism as illustrated in Fig 7.
Discussion
In the present study, LC-MS-based metabolomic analysis technology was used to identify char-
acteristics of the metabolite profiles of mice infected with T. gondii and to discover biomarkers
that discriminate T. gondii-infected from non-infected controls. LC-MS based metabolomic
profiling studies have become an increasingly powerful tool to analyze the interaction between
parasites and their hosts, such as malaria caused by another apicomplexan protozoan Plasmo-
dium falciparum [27,28] and human African trypanosomiasis (HAT) [29]. In these studies,
marked alterations in host’s metabolic profiles were detected and some perturbed metabolites
were identified as biomarkers with a potential diagnostic value. Likewise, in our study we have
profiled the dynamic metabolic changes in mice brain infected by T. gondii Pru strain over the
course of 21 DPI. We found metabolic shifts between T. gondii infected and non-infected mice
as well as between T. gondii infected mice at different time points post infection.
Infected mice began to exhibit clinical signs of toxoplasmosis at 7 DPI. As the disease pro-
gresses, mice exhibited typical symptoms of acute infection around 11 DPI. Although some mice
also become more dispirited, less energetic, and exhibited weight loss and reduced physical activ-
ity at 14 DPI, they appeared to regain health. Most infected mice regain health at 21 DPI, which
correlated with increased appetite and improved physical activity. Pathological studies demon-
strated significant structural changes occurred by 21 DPI, including inflammatory cell infiltration
and the presence of parasite cysts, which are correlated with the changes of brain metabolism.
Brain samples were collected at different time points (7, 14 and 21 DPI) and analyzed to
profile the parasite-induced metabolite changes related to the brain injury. OPLS-DA as a
supervised pattern recognition process was necessary to maximize the variation associated
with the mice health status. Each data point represents one brain sample, and the distance
between points in the score plot is an indication of the similarity between samples. The score
plots showed that all the infected groups could be easily distinguished from the corresponding
control groups and the infected groups at different time points could also be clearly separated.
Both T. gondii infected and uninfected mice brains were analyzed to determine the parasite-
induced alterations to normal brain metabolism. Mice at the early infection stage (7 DPI)
Table 3. Marker metabolites found in LC/MS chromatograms of control and infected groups at 14DPI.
Ion mode Metabolite Rt (min) Chemical class P-valuea
ESI(+) Propionyl-L-carnitine 0.952499 Fatty ester 0.028171
ESI(+) Guanine 1.235958 Base 0.020226
ESI(+) Guanosine 1.237643 Nucleoside 0.000632
ESI(+) Inosine 1.261978 Alkaloid 0.000264
ESI(+) Hypoxanthine 1.262799 Purine nucleoside 0.000646
ESI(-) Ascorbic acid 1.937837 Vitamin 0.01134
ESI(-) Docosahexaenoic acid 14.65844 Fatty acid 0.006129
ESI(-) Arachidonic Acid 14.82713 Fatty acid 0.018173
a Statistical p-value calculated using a two sample t-test (signiﬁcance at p < 0.05).
doi:10.1371/journal.pone.0139635.t003
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showed a slight shift in metabolism, which was marked by an increase of UDP-N-acetyl-D-
galactosamine (ESI-) and a decrease of leukotriene D4 (ESI+). Most of the detected metabolites
showed peak or minimum abundance at 14 DPI, a period close to the acute infection [30]. The
metabolome closely reflects the activities of the brain at the functional level and the metabolites
that fluctuated with disease progression are indicative of the major metabolic processes that are
closely related to the regulation of T. gondii infection. For example, cytidine, a decomposition
product of cytidine monophosphate (CMP), was down-regulated along with the L-aspartic acid,
which is an important building block of the de novo pyrimidine biosynthetic pathway in T. gon-
dii. Arginine follows a similar profile. Previous studies showed arginine starvation could trigger
differentiation of tachyzoites to bradyzoites, the slowly replicating stage contained within stable
cyst-like structures [31]. These findings demonstrate that alteration of host metabolites (e.g.
arginine) can modulate T. gondii phenotype (tachyzoite-bradyzoite) switching, an integral part
of the infection process, which enables the parasite to hide inside host cells.
It is well established that the glucose is the primary energy source for brain. However, under
starvation or fasting conditions, fatty acids could substitute glucose as an alternative substrate
for brain energy metabolism. With regard to dietary intake by infected mice and energy
demands for survival, the metabolite profiles of carnitine and lipid species in the brain is very
worthy of attention. Significantly altered carnitines and phospholipids indicate variation of
fatty acids oxidation metabolism and phospholipids metabolism, respectively. For example,
acetyl-carnitine, an acetyl derivative of L-carnitine, was found to be more abundant in the
infected mice group, which is consistent with others [32]. Acetyl-carnitine is involved in fatty
acids oxidation metabolism, in which its acetyl groups are mostly incorporated into saturated
fatty acid [33]. Apart from its role in reducing oxidation of glucose, acetyl-carnitine also takes
part in many neuro-protective roles [34–36]. Propionyl-L-carnitine, playing a significant role
in fatty acid oxidation and energy expenditure, were also shown to be more abundant at the
same time [37]. Phospholipid is a major component of all cell membranes as it forms the phos-
pholipid bilayer. Variations of PC, PI, PA and PE levels were observed between infection mice
and the healthy ones (Table 1). The precursors of membrane phospholipids, phosphocholine
and phosphoethanolamine, were down-regulated due to the presence of T. gondii infection.
Phosphocholine is an intermediate in the synthesis of phosphatidylcholine, during which ATP
Fig 7. The schematic of purine metabolism diagram illustrating the biological significance of some biomarkers for prediction of physical recovery
of illness. (□means that the biomarkers were obtained in this experiment).
doi:10.1371/journal.pone.0139635.g007
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and choline are converted into ADP and phosphocholine via catalysis by choline kinase.
Phosphatidylethanolamine, synthesized by phosphoethanolamine, is found in all living cells,
especially in nervous tissues. The decline of these two metabolites might be bound up with
reduced food intake.
Mentally, infected mice exhibited lethargy and energetic dispirited, which might link with
the metabolites variations. For instance, taurine is the second most abundant amino acid in the
CNS, which showed significantly decreased levels at this period. Taurine functions as a key reg-
ulator of neuronal activity, neuromodulator and osmoregulator [38]. Moreover, it takes part in
the development and survival of neural cells [39]. Gama-Aminobutyric acid (GABA), as the
main inhibitory neurotransmitter in the CNS, also showed similar profile, which is found to
function in reducing neuronal excitability [40].
The physical condition of infected mice becomes improved by 21DPI. The number of
metabolites with statistically significant variations in abundance decreased at this period.
Metabolites that were involved in the restoration of physical fitness of mice were elevated. For
example, glutathione, as an important antioxidant, was up-regulated in the infected mice. Glu-
tathione assists in the defense against reactive oxygen species generated during oxidative
metabolism and also plays an important role in DNA repair and protein synthesis [41–43].
Direct comparisons of metabolite levels between day 14 and day 7 PI showed the most dra-
matically changed metabolites as shown in Table 2. Pantothenic acid, also known as vitamin
B5, was significantly elevated with the log2 fold change of 1.78. Pantothenic acid is required for
the synthesis of coenzyme A (CoA) that is involved in metabolism of fats, carbohydrates, and
amino acids [44]. Acetyl coenzyme A (Acetyl-CoA) derived from CoA under acylation reaction
was down-regulated. This metabolite participates in many essential metabolic pathways, such
as citric acid cycle, glycolysis and fatty acid metabolism. Acetyl-CoA is also involved in the bio-
synthesis of the neurotransmitter acetylcholine. Choline and phosphocholine are other two
metabolites that showed lower abundance, which are involved in the synthesis of acetylcholine.
The deficiency of these metabolites might be directly bound up with abnormal physical activi-
ties. Oxoglutaric acid, also called α-ketoglutaric acid was the highest abundance metabolite
when comparison was made between day 21 and day 7 PI. Oxoglutaric acid is an important
intermediate in the tricarboxylic acid cycle and is involved in the synthesis of glutamine. The
number of significantly changed metabolites between 21 and 14 DPI is small, which might
account for health recovery at the metabolism level.
On day 14 PI, although demonstrating obvious pathogenic signs, more than half infected
mice had already begun to recover. Marker metabolites that were responsible for the separation
of the day 14 infected mice group from the control group were summarized in Table 3. The lev-
els of all these metabolites were found to be statistically different (p< 0.05) and marker metab-
olites selected in this period were involved in many crucial metabolic pathways. For example,
guanosine, guanine, hypoxanthine and inosine, intermediates in the purine salvage pathway,
reached their peak abundance at 14 DPI. For the host, purine salvage pathway is the main way
for purine synthesis in the brain. Purine salvage pathway is considered more energy efficient
and integral to the cause or treatment of a number of human diseases of purine metabolism
[45]. Because T. gondii is not able to synthesize purines de novo, it is more reliant on the purine
metabolic enzymes and intermediates in the purine salvage pathway to ensure growth [46]. As
the parasite’s sole source of purine bases, this salvage pathway is also essential for cyst growth
and has been considered a potential target of new anti T. gondii drugs [47].
In conclusion, metabolomic analysis yielded a clear separation between non-infected and T.
gondii-infected mice groups, indicating a substantial imprint from the infection on the metabo-
lism of mice during the progression of the disease. In a longitudinal study, the strongest separa-
tion occurred around 14 DPI. Altered metabolomic pathways included changes in
Metabolomic Profiling in T. gondii Infected Mice Brains
PLOS ONE | DOI:10.1371/journal.pone.0139635 October 2, 2015 18 / 22
carbohydrate metabolism, lipid metabolism, energetic metabolism and fatty acid oxidation.
Perturbed metabolites and pathways detected in this study may provide valuable information
for discovery of new targets for novel therapeutic and diagnostic applications. Although bio-
marker discovery using experimental infections has the benefit of documenting when the bio-
marker detects the infection, validation of the use of metabolomics to detect infection under
field conditions will need to be done to ultimately demonstrate its utility.
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S1 Fig. Differential metabolic profiles in mice brain among the six mice groups and during
the time courses of toxoplasmosis. (A) LC-MS based PCA scores of brain of mice with/with-
out infection with T. gondii in positive ion mode. (B) LC-MS based PCA scores of brain of
mice with/without infection with T. gondii in negative ion mode. QC means quality control
samples.
(TIF)
S2 Fig. Comparison of the mice brain metabolomes during the course of infection.Heat
maps representing the significantly changed metabolites between infected groups and the cor-
responding control groups in ESI- mode (A, B and C). Normalized metabolite abundance (log2
transformed and row adjustment) are visualized as a color spectrum and the scale from least
abundant to highest ranges is from -2.0 to 2.0. Green indicates low expression, whereas red
indicates high expression of the detected metabolites. (A) 7D infected group (7I) vs 7D control
(7C); (B) 14D infected group (14I) vs 14D control (14C); (C) 21D infected group(21I) vs 21D
control (21C).
(TIF)
S3 Fig. Heat map showing the significantly dysregulated metabolites identified between
different infected groups in ESI- mode.Heat maps show a clear separation of the metabolo-
mic profile between different infected groups. Normalized metabolite abundance (log2 trans-
formed and row adjustment) are visualized as a color spectrum and the scale from least
abundant to highest ranges is from -2.0 to 2.0. Green color indicates low expression, and red
color indicates high expression of the detected metabolites. (A) 7D infected group (7I) vs 14D
infected group(14I); (B) 7D infected (7I) group vs 21D infected group (21I); (C) 14D infected
group (14I) vs 21D infected group (21I).
(TIF)
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